Clinical trials
Prostate clinical trials
Below are recruiting prostate clinical trials, each written for real people, not researchers. We’re tracking 1,368 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06966024RecruitingPhase 1
Study of DCC-2812 for advanced genitourinary cancers
This trial tests an experimental pill called DCC-2812 for people with advanced kidney, bladder, or prostate cancer. The goal is to see if it is safe and if it might help shrink tumors or slow the cancer's growth.
Boston, MassachusettsAges 18 years+ - NCT05463796Recruiting
Prevention and early detection for people at high cancer risk
This study looks at surveillance (watching closely), prevention, and early “interception” steps to lower the chance that cancer will develop or be found later. It is for people with genetic risk, past cancer treatment exposures, strong family history, or certain early pre-cancer or high-risk conditions.
Boston, MassachusettsAges Any age - NCT06717711RecruitingPhase 3
Shockwave therapy for penis recovery after prostate cancer surgery
This trial tests if low-intensity shockwaves can help men regain erectile function after robot-assisted prostate surgery. If you had nerve-sparing surgery and have good erections before treatment, this may help you recover faster.
Rome, RMAges 18–75 - NCT06995898Recruiting
Blood test study for early cancer detection
This study is testing a new blood test that may help find cancer early. You will give blood samples over a year, and researchers will check them for signs of cancer.
Pleasanton, CaliforniaAges 45–75 - NCT05543200Recruiting
BPH symptom registry for people needing treatment
This trial is a global registry that collects information about people with an enlarged prostate (BPH) who have urinary symptoms and are receiving treatment. It may help researchers better understand which treatments work best and how symptoms change over time.
Los Angeles, CaliforniaAges 18 years+ - NCT07227077Recruiting
Physical activity study for older cancer survivors with chronic pain
This study uses a smartphone program to encourage physical activity in older adults who have survived cancer and have ongoing pain. It aims to learn how to best help you move more and feel better.
Milwaukee, WisconsinAges 65 years+ - NCT07760688Recruiting
Nursing care during prostate biopsy in men
This study tests whether structured nursing care during and after a prostate biopsy can improve your experience and outcomes. It may help reduce discomfort or anxiety related to the procedure.
Mostar, Federation of Bosnia and HerzegovinaAges 40 years+ - NCT05923684Recruiting
English prostate cancer visit feedback tool for shared decisions
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
Los Angeles, CaliforniaAges 18 years+ - NCT06469710Recruiting
Collecting cancer cells from blood in metastatic prostate cancer
This trial is testing a blood-filtering procedure (leukapheresis) to collect special cancer cells that have broken away from the tumor. It may help doctors better understand your prostate cancer and guide future treatment.
ShanghaiAges 18–75 - NCT03824652RecruitingPhase 2
Walnuts and omega-3 to help weight loss before prostate surgery
This Phase 2 study tests whether adding walnuts (and related nutrients like omega-3s) can help with weight loss and energy in people with prostate cancer who are planning prostate removal surgery. It aims to see if diet changes improve how you feel and manage weight before and around treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07549256RecruitingPhase 2
Cannabidiol for Pain Relief in Advanced Prostate Cancer
This trial tests whether cannabidiol (CBD), a non-intoxicating cannabis compound, can help relieve pain in patients with advanced prostate cancer that has stopped responding to standard treatments. You would take CBD daily alongside your current morphine pain medication.
GistrupAges Any age - NCT06751329RecruitingPhase 1/Phase 2
Study of DM002 for advanced solid tumors
This trial tests a new drug called DM002 for people with advanced solid tumors that have not responded to standard treatments. The drug targets two proteins (MUC1 and HER3) found on some cancer cells, and may help shrink tumors or slow their growth.
San Francisco, CaliforniaAges 18 years+ - NCT05573048Enrolling by invitation
MRI-guided biopsy or treatment using a perineal grid approach
This study looks at a new way to do an MRI-guided prostate biopsy or ablation using a small “grid” approach through the area between the scrotum and anus. It may help doctors target suspicious spots on MRI more precisely while keeping the procedure safe.
Rochester, MinnesotaAges 45 years+ - NCT05155046RecruitingPhase 2
Scan to check prostate cancer response after focused radiation
This study tests whether a special PET scan tracer (18F-DCFPyL) can show how well focused radiation (SBRT) is working for localized prostate cancer. It may help doctors spot treatment response earlier and tailor follow-up care.
Bethesda, MarylandAges 18–120 - NCT07705334RecruitingPhase 1
Study of SHY-ONC6 for advanced solid tumors
This trial tests a new drug called SHY-ONC6 that targets and breaks down cancer cells. It's for people with advanced solid tumors that haven't responded to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT07114601RecruitingPhase 1
Study of LY4257496 for people with GRPR-positive solid tumors
This trial tests a new drug, LY4257496, in people with certain types of cancer that have a protein called GRPR on their cells. The study aims to see if the drug can help shrink tumors or slow the cancer's growth.
Duarte, CaliforniaAges 18 years+ - NCT06966778Recruiting
Oxybutynin to help bladder control after prostate surgery
This trial tests if the medicine Oxybutynin ER (a drug that helps relax the bladder) can help you regain bladder control sooner after robotic prostate surgery. Participants will be randomly assigned to receive either the drug or a placebo for a few weeks after surgery.
TaipeiAges 18 years+ - NCT06832774RecruitingPhase 2
Hormone therapy plus local treatment for advanced prostate cancer
This study tests adding a targeted local treatment (like radiation or surgery) to standard hormone therapy for men with advanced prostate cancer that still shows up on a special scan. The goal is to see if this combination helps control the cancer better.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06825715Recruiting
Precision oncology support for lung and prostate cancer
This study tests a program to help veterans with lung or prostate cancer get personalized cancer treatments. The goal is to see if extra support for doctors and patients leads to better use of precision medicine.
New York, New YorkAges Any age - NCT06446648RecruitingEarly Phase 1
Green dye to improve recovery after prostate cancer surgery
This trial tests whether using a green dye (ICG) during robot-assisted prostate removal helps preserve urinary and sexual function. It is for men with localized prostate cancer and good baseline erectile function.
Orange, CaliforniaAges 18 years+ - NCT06241846RecruitingPhase 2
Study of YL201 for advanced prostate cancer that has spread and stopped responding to hormone therapy
This trial tests a new drug, YL201, in men with advanced prostate cancer that has spread and is no longer controlled by standard hormone therapy. The goal is to see if YL201 can shrink tumors or slow the cancer's growth.
Hefei, AnhuiAges 18 years+ - NCT05956639RecruitingPhase 3
Rezvilutamide with ADT and chemo: shorter versus longer treatment
This Phase 3 trial compares two lengths of rezvilutamide treatment when given with hormone therapy (ADT) and chemotherapy for men with advanced prostate cancer. It aims to find which treatment duration works best and is safest to help control the cancer.
Nanjing, JiangsuAges 18 years+ - NCT06136624RecruitingPhase 3
Comparing a new drug to standard hormone therapy for advanced prostate cancer
This trial tests a new pill, opevesostat, against other hormone treatments for men with metastatic castration-resistant prostate cancer that has progressed after previous therapies. It aims to see which approach works better.
Orange, CaliforniaAges 18 years+ - NCT06126731RecruitingPhase 1/Phase 2
Antibiotics plus enzalutamide for advanced prostate cancer
This trial tests whether adding specific antibiotics (amoxicillin, metronidazole, vancomycin, ciprofloxacin) to enzalutamide can help treat advanced prostate cancer that has stopped responding to other treatments. It aims to see if changing gut bacteria can make the cancer therapy work better.
BellinzonaAges 18 years+
Hear when a new Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prostate?
- Yes. Clin2 currently lists 1,368 recruiting prostate studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prostate trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prostate trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.